Anticancer agent 132

Compound Rh1 (Anticancer agent 132) is a multi-functional small molecule that induces apoptosis and autophagy, leading to cell cycle arrest and suppressed proliferation. Its antitumor and antimetastatic activities have been demonstrated in both in vitro and in vivo cancer research models.